Search Results
Showing 16 of 16 results
Addressing the Unmet Needs of Inflammatory Bowel Disease Patients
Approximately 4 9 million people worldwide live with inflammatory bowel disease IBD a chronic inflammatory disease affecting the digestive system IBD is the collective term referring primarily to two conditions ulcerative colitis UC and Crohn s disease CD Teva is currently investigating a new treatment for the condition
A Passport to Career Development A Journey with Teva s R D Teams
Join Jessica Payne device engineer and member of the Combination Products and Devices team at the Teva Research Development lab in West Chester US on a project focused assignment at Teva sites in Ireland and Croatia
Pivot to Growth The Teva Journey
Mapping the journey of Teva s Pivot to Growth strategy
Meet Our People Beryl Ojwang
Beryl Ojwang MD MBA MPH Associate Medical Director Oncology Biosimilars North America Medical Affairs shares how artificial intelligence is bringing patient insights to Teva scientists
New R D Facility in Hungary will Double Annual Testing Capability
Go behind the scenes at Teva to Debrecen in Hungary where a new 2 4 million R D facility is helping to speed up production and get medicines to patients faster
Democratizing Science Big Pharma Joins Forces with Academia
Building cross sector and multidisciplinary collaborations developing innovative technology and supporting the next generation of entrepreneurs will all play an important part in developing the medicines of the future An industry shift in attitudes and working patterns is needed to embrace this new age and find new ways of operating At Teva this shift has already started
3 Trends I m Watching in Pharmaceutical Marketing and Digital
Alyssa Fenoglio VP Global Head of Digital Commercial at Teva shares the key trends she s watching in her sector
What are Biologics and Biosimilars
We explain the difference between biologics and biosimilars and showcase Teva s innovative work in this space
How Can We Use AI to Make Medicines More Efficiently
Teva s Chief Medical Officer Eric Hughes outlines the key efficiencies to be gained from artificial intelligence AI
The Three Women Who Inspired Me
Eric Hughes Teva Pharmaceuticals Head of Global R D and Chief Medical Officer shares stories of the three women who shaped his journey and whose impact has inspired him personally and professionally
Revolutionary Innovations in Medicine Propelled by AI and Cross Industry Collaboration
Take a look inside Israel s AION Labs which is being supported by Teva to transform the way big pharma works with the aim of discovering new medicines faster cheaper and more precisely
What Took Us Years Could Now Take Half the Time Innovation Is Redefining Pharma
AI and other technologies have significantly shortened the R D process in the pharma industry Dr Eran Harary of Teva Pharmaceuticals sheds light on innovation
Breaking Boundaries How Diversity Fuels Innovation in Teva s R D Management Team
Meet Heather De Luca Head of Global Program Leadership R D Eric Hughes Head of Global R D and Chief Medical Officer and Sophie Lamle SVP Head of Innovative Medicines R D Together they offer valuable insights into how diversity particularly gender influences the development of groundbreaking ideas and solutions
Can AI driven digital biomarkers redefine diagnostics and clinical trials
Artificial Intelligence and advanced analytics technologies have huge potential to improve the world of health We talk to Teva employees who are using the technologies
Digital Health The new standard
Asthma and COPD affect over 500 million people worldwide Learn more from Sven Dethlefs EVP Global Marketing Portfolio and International Markets as he discusses how Teva is trying to address respiratory diseases through digital health solutions
